Spots Global Cancer Trial Database for Study of ONO-4578 With and Without ONO-4538 in Subjects Advanced or Metastatic Solid Tumors
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Study of ONO-4578 With and Without ONO-4538 in Subjects Advanced or Metastatic Solid Tumors
Official Title: Phase 1 Dose Escalating and Expansion Study of ONO-4578 Given as Monotherapy and Combinations of ONO-4578 and ONO-4538 in Subjects With Advanced or Metastatic Solid Tumors
Study ID: NCT03155061
Conditions
Study Description
Brief Summary: The objective of the study is to evaluate the safety, tolerability, pharmacokinetics, efficacy and biomarker of ONO-4578 and combinations of ONO-4578 and ONO-4538 in subjects with advanced or metastatic solid tumors and subjects with unresectable, advanced or recurrent gastric cancer, unresectable, advanced or recurrent colorectal cancer.
Detailed Description:
Keywords
Eligibility
Minimum Age: 20 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Aichi Clinical Site 1, Nagoya, Aichi, Japan
Aichi Clinical Site 2, Toyoake, Aichi, Japan
Chiba Clinical Site 1, Kashiwa, Chiba, Japan
Ehime Clinical Site1, Matsuyama, Ehime, Japan
Gunma Clinical Site 1, Ota, Gunma, Japan
Hokkaido Clinical Site 1, Sapporo, Hokkaido, Japan
Iwate Clinical Site 1, Yahaba-cho, Iwate, Japan
Kanagawa Clinical Site 2, Sagamihara, Kanagawa, Japan
Kanagawa Clinical Site 1, Yokohama, Kanagawa, Japan
Osaka Clinical Site 2, Hirakata, Osaka, Japan
Osaka Clinical Site 3, Sakai, Osaka, Japan
Osaka Clinical Site 4, Takatsuki, Osaka, Japan
Saitama Clinical Site 2, Hidaka, Saitama, Japan
Saitama Clinical Site 1, Ina-machi, Saitama, Japan
Shizuoka Clinical Site 1, Nagaizumi-Cho, Shizuoka, Japan
Tokyo Clinical Site 1, Chuo-ku, Tokyo, Japan
Tokyo Clinical Site 4, Itabashi-ku, Tokyo, Japan
Tokyo Clinical Site 2, Koto-ku, Tokyo, Japan
Tokyo Clinical Site 3, Shinjyuku-ku, Tokyo, Japan
Fukuoka Clinical Site 1, Fukuoka, , Japan
Fukuoka Clinical Site 2, Fukuoka, , Japan
Osaka Clinical Site 1, Osaka, , Japan
Contact Details
Name: Project Leader
Affiliation: Ono Pharmaceutical Co. Ltd
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
